Date | Subject | Author | Discuss |
---|
20/7/2021 13:11:28 | Looks ready for rebound to me. Fall overdone, based on Arnab's positivity & comments from last week & future potential, not just covid related products of course. |  davethechef | |
20/7/2021 12:19:14 | 2nd attempt..only on my mobile..fat finger!!
If it's been Rns'd I would believe it. But only a couple of weeks one jurno report said it had cost a million pounds to develop, which seemed unlikely today it's £14 million, I'm sure it's somewhere in between as the projects are ongoing and overlapping.
So a Jurno' miss Qoute would think about total contracts.
It is hard to keep up with all the US , UK Innovation' and now recent Mod monies.
Someone's confident in Kromek's design and development abilities. . DARPA Phase 1 - £1.47 (2 million dollars). Start Dec 2018
DARPA extended £3.8 (up to 5.2 mil dollars) 27/5/20
DARPA Phase 2 - £4..3 ( 5.9 mil dollars) 14/06/21
UK inovate -. . £1.25 million program
Uk MoD - £349k
£1.47 + 3.8 + 4.3 +1.25 + 0.349 = £11.2 million
or 15.27million dollars @ today's ex
But I don't think you'll ever hear Kromek refer to the DARPA funded work as "grants".
The DARPA work coming with strict Contract criteria, milestones and targets to be meet. and all these overlap a bit.
14th June 2021 Vox site
'' $6m contract win for breakthrough biothreat detector'' 'Today, pioneering radiation detection firm Kromek said that it had received a $6m follow-on order from DARPA. Covering Phase II of its development of a biological threat detector'
The latest MOD recent announced Just last week-
'In its new target area of biological-threat detection, Kromek has been awarded a £349,000 contract with the UK Ministry of Defence, through its Defence and Security Accelerator Open Call for Innovation programme, to develop its technology to meet defence and security requirements for wide-area monitoring of biological pathogens.' |  33mick | |
20/7/2021 10:22:44 | Nobody interested anymore. This has been a traders share without doubt. share price sliding down again. |  b00mb0y | |
20/7/2021 08:47:59 | The Northern Echo seems to be the place to go to read about Kromek! £14m to develop? Is that right? So Kromek have been using their own money, not just gov grants? |  aqc888 | |
20/7/2021 08:43:54 | hxxps://www.thenorthernecho.co.uk/news/19453036.durham-school-trial-new-airborne-covid-detection-system/ |  aqc888 | |
19/7/2021 20:52:50 | The vaccine data from the Israelis, normally well ahead of the game, has spoked the market big time. The fear of a stalled restart is far worse than any inflation fears.If this can get to market, what an opportunity for the company |  dexter1612 | |
19/7/2021 19:31:32 | Anyone here think a takeover/ buyout possible? |  b00mb0y | |
19/7/2021 17:09:25 | This dip, based on the delta variant, will make Kromeks news all the more relevant- if positive results are unveiled... |  aqc888 | |
19/7/2021 16:11:37 | Everyone has different positions. But personally I never make any decisions on share price on the basis of one day's trading. |  dexter1612 | |
19/7/2021 15:26:21 | Almost everything is down. Seems you need to have released very positive news or make popular vacinces to be up or holding ground today. If we had a fully validated and in production covid detector than I imagine Kromek would be among the few risers. Until then we need to be patient. |  petersw1 | |
19/7/2021 14:55:22 | More meaty buys than sells now, it seems. Earlier 3 x 125k's etc but admittedly a couple of 100k sells. May have bottomed for now, who knows!?! The MM love to drop it quite some then get 'twitchy' & can't decide whether to drop it further or reverse it; all on relatively small volume. |  davethechef | |
19/7/2021 14:43:51 | Don’t seem like anyone has any interest in this stock anymore! All have lost faith in IC’s Simon Thompson too. Is this going back to .12s? Ffs. |  b00mb0y | |
19/7/2021 08:39:38 | As annoying as it is, I’ve just got to sit and wait for the scientific results to be released. I remind myself of the excellent track record Kromek scientists have, when I get worried watching the Kromek CEO and his floundering statements etc.
This companies success will all be about this SCIENTIFIC result we are waiting for. All other factors are just noise until they are released. |  aqc888 | |
19/7/2021 07:12:41 | Commercialisation of the machines should be by the end of the year ST says, so not too far off hopefully. I was a bit disappointed last week that the very positive article & ‘strong buy’ recommendation in IC had only a mild effect on the share price. Could see more buying today hopefully as people read it over the weekend. I’m wondering if the CEO regarding his ‘coming days’ statement was referring to his team getting and going through the results in the coming days? Massively misleading to investors. Any results would need to be accredited by a third party laboratory anyway for them to be worth anything. Who’s going to believe some AIM company without third party accreditation? Not many people I suspect |  aqc888 | |
18/7/2021 22:52:40 | Hi Dave, this is the Equity interview where Arnab says the prototype s will be ready for testing from March onwards...someone did state on LSE incorrectly that they had started before they had...there was another interview when Arnab confirmed the actual trials had started..early .Apr? I believe..BUT not at the begining of the year.
Then Paul Hill confirmed they would take some months...so things are about on track.
Arnabs 'in the coming days' when he meant weeks? was just a genuine slip up, it happens.
From my post in Lse- 10th Feb
"RE: KMK a lot to look forward too 10 Feb 2021 14:31 This was the last interview with Equity on the 16th Jan and Arnab mentions 6-7 mins in that the New Bio Dection Unit will be ready for Piloting from March onwards....I think we'll hear about it when it starts...not long to wait now.."
They didn't even have the full design team in place then as he says..just built it up to 20 strong think he's mentioned. |  33mick | |
18/7/2021 21:42:28 | I'm late to this company so 100% am no expert. However, on the timeline for results, I would say its vital that they have confidence in the data. Checked, cross checked and double checked, incorporated into test and trace applications etc.....this will take time and is probably the most important aspect of the entire device, user confidence. I wouldn't be alarmed by any perceived delay...just my thoughts. |  dexter1612 | |
18/7/2021 20:58:30 | Well put, Davethechef. My thoughts exactly. Some say exiting times ahead. I say quite daunting. Yet im hopeful. |  b00mb0y | |
18/7/2021 20:47:23 | I'm in two minds about this share especially recently. It could have great potential IF it ends up selling a lot of the covid detectors but that is a long way off. However, I'm still disappointed & puzzled on why Kromek haven't given out the much laundered & CEO promised positive trial results by now. Why!?! The " coming days" was stated many weeks ago now. Is this still not the case, a over- exaggeration? & waiting on those further trials instead, like the NHS etc to bolster them. Who knows!?! The Results Rns of last week, for me, didn't have enough detail, didn't mention the trials which started at the start of 2021 which we were led to believe, mentioned end of last year. Surely 6 months of trials is sufficient time. We will need substantial orders. DARPA continues to be a good customer & news of Government's interest excites but it looks to me, like it'll take some time for firm orders to develop. Their technology is possibly world- beating but there will be competitors emerging, in time, with maybe better PR & sales-team to back-them. Come on Arnab!!! |  davethechef | |
17/7/2021 13:09:34 | I have bought in over the last few months and will continue to add at these levels. I believe the products are top class and there seems to be a spirit of continuous improvement and innovation. The numbers though are ok but not brilliant, assuming they get income up to about £20m this year then that looks about breakeven, I am unsure if they can make this with their existing product mix so it may rely on some income from new products, however again assuming additional income does not significantly increase admin expense and the factories have capacity then anything extra will drop through to the bottom line. I guess if their operational gearing cant cope then they follow a licencing model. The new chair will hopefully inject more realism and discipline thus enabling this to become a UK champion. |  andrew97 | |
17/7/2021 12:29:05 | I'm new here but the point about science& technology versus finance&business is a very relevant one. The most successful investors in technology have been able to find the balance of allowing the innovators and scientists the space and capacity to flourish without the added pressure of shareholder expectation. Its all about being a patient and good partner.If you believe in the fundamentals, the results will happen. I think this is more prescient than ever, with Moores law and the rapid changes to our lives with technology that have definitely been accelerated by the pandemic....thats what attracts me to this space in particular. |  dexter1612 | |
17/7/2021 12:10:54 | There is alot of frustration from investors over the management from the past few years, with a lot of disappointments.
However what we are waiting for here is a scientific result, not a business result. A lot of other people posting on lse and advfn are constantly criticising the management of Kromek (including myself). But I’d say we should be careful about blurring the two.
Kromeks scientific results have been consistently first class in the other products they develop, often world leading. Management results have been consistently poor.
The potential scale of this scientific result we are waiting for would be difficult for even a poor management team to squander. The new Chairman this year should also have the experience to provide good steady guidance |  aqc888 | |
17/7/2021 11:50:56 | Headline in a paper today suggests lockdowns will return in September... just as machine is due to be released... but remember the uk is only a very small part of the global demand this machine will have if it works |  aqc888 | |
17/7/2021 11:47:47 | “ expect some exciting news within the next few months” Simon Thompson IC. Also “commercial roll out later this year”.
I’d be interested to know if the machine detects all covid strains or needs different settings/machine for each different strain? |  aqc888 | |
17/7/2021 10:54:12 | What's the timeline for the results? I see product is already being trialled. A matter of weeks, months?Given that it's fairly certain of an acceleration of infections and new variants over the coming months and approaching peak winter, is it safe to assume that it will be expidiated to market if viable? |  dexter1612 | |
17/7/2021 10:37:45 | I don’t think anyone should underestimate the difficulty in achieving what Kromek are trying to do with this machine. I remember reading an article a leading scientist in the field (I posted it previously but can’t remember where it was from) saying what a difficult task it was. Comparing it to finding a needle in a haystack.
Personally I’d give it a 50:50 chance of working. The positivity from ST and constant positivity from the CEOs comments encourage me slightly.
BUT since the potential earnings from the Biopathogen detector isn’t priced in to the share price AND Kromek haven’t used any of their own money to develop it (US&UK grants). It seems that Kromeks regular business is performing well by itself without this machine. So we are basically getting a free ride on a 50:50 chance of the detector actually working. A detector which will completely re rate the share price. I’ve increased my holding to just under 10% of my portfolio. I don’t like investing in individual companies at all like this but this is an exception and I’m very nervous about doing this. I’m up 17% so far on Kromek and keeping a very close eye on what’s going on here, can’t wait to hear the results |  aqc888 | |